Genmab A/S Stock

Genmab A/S P/CF

The P/CF (Price-to-Cash-Flow Ratio) of Genmab A/S (GMAB.CO) as of Jul 21, 2026 is 14.10. In the previous year, P/CF (Price-to-Cash-Flow Ratio) was 14.84 — a change of -4.97% (lower).

P/CF

14.10

YoY

-4.97%

Last updated:

P/CF (Price-to-Cash-Flow Ratio) of Genmab A/S is 2026 14.10 . P/CF (Price-to-Cash-Flow Ratio) of Genmab A/S was 2025 14.84 . It decreases by -4.97% lower compared to the previous year.
Access this data via the Eulerpool API

Genmab A/S Stock analysis

What does Genmab A/S do? Genmab A/S is a Danish biotechnology company specializing in the discovery and development of antibody therapies for cancer and other serious diseases. The company was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab A/S stock

P/CF (Price-to-Cash-Flow Ratio) of Genmab A/S is 14.10 in 2026.

Access this data via the Eulerpool API

Valuation — Genmab A/S

All Key Metrics — Genmab A/S